The Long-Term Cost Effectiveness of Treatments for Benign Prostatic Hyperplasia

被引:0
|
作者
Rachael L. DiSantostefano
Andrea K. Biddle
John P. Lavelle
机构
[1] School of Public Health,Department of Health Policy and Administration
[2] University of North Carolina at Chapel Hill,Carolina Program in Healthcare and Aging Research
[3] Institute on Aging,Division of Urology
[4] University of North Carolina,undefined
[5] School of Medicine,undefined
[6] University of North Carolina,undefined
来源
PharmacoEconomics | 2006年 / 24卷
关键词
Benign Prostatic Hyperplasia; Lower Urinary Tract Symptom; Urinary Symptom; Watchful Waiting; Utility Weight;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:171 / 191
页数:20
相关论文
共 50 条
  • [31] LOCALIZED DEEP MICROWAVE HYPERTHERMIA IN THE TREATMENT OF BENIGN PROSTATIC HYPERPLASIA - LONG-TERM ASSESSMENT
    YERUSHALMI, A
    SINGER, D
    KATSNELSON, R
    LEVY, E
    SHANI, A
    BRITISH JOURNAL OF UROLOGY, 1992, 70 (02): : 178 - 182
  • [32] Transurethral hyperthermia for benign prostatic hyperplasia: Long term results
    Petrovich, Z
    Pike, MC
    Boyd, SD
    Jozsef, G
    Astrahan, MA
    Baert, L
    INTERNATIONAL JOURNAL OF HYPERTHERMIA, 1996, 12 (05) : 595 - 606
  • [33] Long-Term Followup after Electrocautery Transurethral Resection of the Prostate for Benign Prostatic Hyperplasia
    Kallenberg, F.
    Hossack, T. A.
    Woo, H. H.
    ADVANCES IN UROLOGY, 2011, 2011
  • [34] Doxazosin for benign prostatic hyperplasia: Long-term efficacy and safety in hypertensive and normotensive patients
    Lepor, H
    Kaplan, SA
    Klimberg, I
    Mobley, DF
    Fawzy, A
    Gaffney, M
    Ice, K
    Dias, N
    JOURNAL OF UROLOGY, 1997, 157 (02): : 525 - 530
  • [35] LONG-TERM URODYNAMIC EFFECTS OF FINASTERIDE IN BENIGN PROSTATIC HYPERPLASIA - A PILOT-STUDY
    KIRBY, RS
    VALE, J
    BRYAN, J
    HOLMES, K
    WEBB, JAW
    EUROPEAN UROLOGY, 1993, 24 (01) : 20 - 26
  • [36] Long-term 6-year experience with finasteride in patients with benign prostatic hyperplasia
    Lowe, FC
    McConnell, JD
    Hudson, PB
    Romas, NA
    Boake, R
    Lieber, M
    Elhilali, M
    Geller, J
    Imperto-McGinely, J
    Andriole, GL
    Bruskewitz, RC
    Walsh, PC
    Bartsch, G
    Nacey, JN
    Shah, S
    Pappas, F
    Ko, A
    Cook, T
    Stoner, E
    Waldstreicher, J
    UROLOGY, 2003, 61 (04) : 791 - 796
  • [37] Transurethral microwave thermotherapy for symptomatic benign prostatic hyperplasia: Long-term durability with Prostcare
    Tsai, YS
    Lin, JSN
    Tong, YC
    Tzai, TS
    Yang, WH
    Chang, CC
    Cheng, HL
    Lin, YM
    Jou, YC
    EUROPEAN UROLOGY, 2001, 39 (06) : 688 - 692
  • [38] Cost analysis of alpha blocker treatments for benign prostatic hyperplasia in Medicare beneficiaries
    Sidi, Yulia
    Duan, Yinghui
    Rhee, Taeho Greg
    Wu, Z. Helen
    RESEARCH IN SOCIAL & ADMINISTRATIVE PHARMACY, 2021, 17 (06): : 1119 - 1139
  • [39] Medical Advancements in Benign Prostatic Hyperplasia Treatments
    Ganesan, Vishnuvardhan
    Agarwal, Deepak
    CURRENT UROLOGY REPORTS, 2024, 25 (05) : 93 - 98
  • [40] Surgical treatments for men with benign prostatic enlargement: cost effectiveness study
    Armstrong, Nigel
    Vale, Luke
    Deverill, Mark
    Nabi, Ghulam
    McClinton, Samuel
    N'Dow, James
    Pickard, Robert
    BMJ-BRITISH MEDICAL JOURNAL, 2009, 338 : 1187 - 1190